Could CAR-T cell therapy be promising agent in acute lymphoblastic leukemia?

CRISPR-Cas9: what is beyond cancer immunotherapy?

New Insights in Role of Cart-T Cell Therapy in Hematological

Genome-editing technologies: Advancement, clinical applications, and ethical concerns

The CRISPR/Cas system: Gene Editing by bacterial defense

Updates in Cancer Immunotherapy: Review Article

An Innovative Epigenetic Merge in Treatment of AML Patients Correlates with Better "Molecular and Clinical” Outcomes

T CELL EXHAUSTION: SUPREMACY IN LEUKEMIA AS FOR DISEASE AND THERAPY

Approaches combining chemotherapy and radiation therapy in locally advanced head and neck cancers: Retrospective record based study

Dendritic cells in cancer immunotherapy from bench to clinic